Bill C-91: The debate continues

Sweeney, George D.
June 1997
Clinical & Investigative Medicine;Jun97, Vol. 20 Issue 3, p193
Academic Journal
Editorial. Focuses on the revisions to the 1993 Patent Act Amendment Act (Bill C-91) in Canada. Provisions of the bill; Costs and profits incurred in drug development; Patent protection as the cornerstone in the legislation of industrialized countries; Sectors benefitted by the bill.


Related Articles

  • Pharmacy industry goes to court. Jones, Llewellyn // Finance Week;11/2/2001, p46 

    Reports on the application of Pharmaceutical Association of South Africa to the High Court on setting aside the registration of Purchase Milton and Associates (PMA). Legislation on the deregulation of the pharmacy industry; Discussions on the draft regulations; Basis on the registration of PMA.

  • Supreme Court hands pharmacy a victory. Ukens, Carol // Drug Topics;5/5/2003, Vol. 147 Issue 9, p25 

    Reports on the U.S. Supreme Court's upholding of Kentucky's any-willing-provider laws. Victory for independent pharmacists who have campaigned to protect their right to join health plan networks; Court's rejection of a case filed in 1997; Implications of the decision on similar laws adopted in...

  • West Virginia assures fair access to drugs.  // Drug Topics;8/7/95, Vol. 139 Issue 15, p7 

    Reports on West Virginia's revised pharmacy practice act which prohibits pharmacists from participating in exclusive networks that deny, limit, or influence the public's access to drugs or services.

  • Techs part of practice act.  // Drug Topics;8/7/95, Vol. 139 Issue 15, p8 

    Reports that North Dakota has included technicians in its revised pharmacy practice act.

  • The Regulation of Pharmacists in Belgium and the Netherlands: In the Public or Private Interest? Philipsen, N.J.; Faure, M.G. // Journal of Consumer Policy;Jun2002, Vol. 25 Issue 2, p155 

    Examines the regulation of pharmacists in Belgium and the Netherlands. Aim of testing the rent-seeking hypothesis discussed in private-interest publications; Analysis of self-regulation issued by professional bodies and public regulations; Restriction of entry into the profession and...

  • Senators want off-label use information sharing. Conlan, Michael F. // Drug Topics;9/4/95, Vol. 139 Issue 17, p21 

    Reports on several senators' co-sponsorship of a legislation that would permit drug firms to disseminate peer-reviewed articles from medical and scientific journals and similar publications.

  • UK medicines legislation under review.  // Health & Homeopathy;Dec2011, p5 

    No abstract available.

  • Medicines Act campaign gathers pace.  // Health & Homeopathy;Summer2012, p6 

    The article reports on a 2012 decision which Great Britain's Medicines and Health Products Regulatory Authority made to develop legislation to make it illegal for British consumers to purchase unlicensed homeopathic medicines online or through the mail. A campaign which has been developed to...

  • New Jersey passes `freedom-of-choice' bill. Muirhead, Greg // Drug Topics;1/10/94, Vol. 138 Issue 1, p68 

    Reports on the passage of New Jersey's `freedom-of-choice' legislation. Effects on third-party plans offered in the state; Efforts by independent pharmacists for the passage of the bill.

  • No phone calls needed. Muirhead, Greg // Drug Topics;10/10/94, Vol. 138 Issue 19, p50 

    Reports on the suspension of the California State Board of Pharmacy's regulation requiring telephone counseling for patients of mail-order pharmacies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics